The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| CCHWF | -67.81% | -97.92% | -53.91% | -99% |
| S&P | +14.5% | +93.32% | +14.09% | +129% |
Columbia Care, Inc. engages in the cultivation, manufacture and provision of medical cannabis products and services. It distributes its products under the Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber, and Platinum Label CBD brands. The company was founded by Nicholas Vita and Michael Abbott in 2012 and is headquartered in New York, NY.
Federal decriminalization hasn't happened yet, but that isn't holding back revenue growth, and investors might soon take notice
Cannabis stocks have taken a beating over the past year, but these three are worth holding on to.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $86.35M | -31.0% |
| Gross Profit | $12.71M | -69.3% |
| Gross Margin | 14.72% | -18.3% |
| Market Cap | $26.75M | -69.2% |
| Market Cap / Employee | $0.02M | 0.0% |
| Employees | 1.7K | -23.3% |
| Net Income | -$77.39M | -467.2% |
| EBITDA | -$7.63M | -135.4% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $15.46M | -30.8% |
| Accounts Receivable | $19.78M | 46.4% |
| Inventory | 70.9 | -38.9% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $432.97M | -7.3% |
| Short Term Debt | $11.53M | -82.9% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -24.84% | -6.5% |
| Return On Invested Capital | -29.23% | 0.4% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$10.36M | -106.1% |
| Operating Free Cash Flow | -$8.48M | -150.8% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 4.58 | 1.23 | -0.78 | -0.42 | -121.18% |
| Price to Tangible Book Value | -2.33 | -0.74 | -0.28 | -0.23 | -92.13% |
| Return on Equity | -153.2% | -176.3% | -140.3% | -554.7% | 342.21% |
| Total Debt | $478.15M | $478.42M | $464.42M | $444.50M | -16.79% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
